Showing results (161-170 of 217) with videos related to
Sort By:
Pageof 22
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancerWillem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung CancerKathryn C Arbour, Laura Mezquita, Niamh Long, et al.Lung Cancer (Amsterdam, Netherlands)|February 20, 2026
Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatmentValentina Bartolomeo, Mandy Jongbloed, Jarno W J Huijs, et al.Cancers|April 30, 2021
EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non-Small Cell Lung CancerRoberto Martin-Deleon, Cristina Teixido, Carmen Mª Lucena, et al.Lung Cancer (Amsterdam, Netherlands)|July 1, 2022
High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trialFenneke Zwierenga, Bianca van Veggel, Lizza E L Hendriks, et al.Cancer Chemotherapy and Pharmacology|November 22, 2022
Renal function-based versus standard dosing of pemetrexed: a randomized controlled trialNikki de Rouw, René J Boosman, Jacobus A Burgers, et al.Lung Cancer (Amsterdam, Netherlands)|September 4, 2025
Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastasesJarno W J Huijs, Anna M Sadowska, Juliette H R J Degens, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint InhibitorsLizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.JTO Clinical and Research Reports|March 29, 2024
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLCJudith L Gulikers, G D Marijn Veerman, Merel Jebbink, et al.Translational Lung Cancer Research|October 24, 2025
Multimodal prehabilitation to prevent loss of cardiorespiratory fitness in patients with locally advanced lung cancer undergoing chemoimmunotherapy: protocol for a non-randomized multicentre studyYu Xiao Chen, Raquel Sebio-Garcia, Maria Jose Arguis, et al.Pageof 22